Dogs: Life partners that meet (almost) all our emotional needs, says study
To carry out their research, scientists at ELTE Eötvös Loránd University in Hungary interviewed over 700 dog owners. These participants were asked to evaluate 13 dimensions of their relationship with their dog, but also with their child, their romantic partner, their closest relative and their best friend. The aim was to understand the place dogs occupy in our lives.
The results are surprising, to say the least. Indeed, it seems that dogs are more than just loyal companions: they combine the qualities of a child with those of a best friend. They evoke a sense of relationship security and the need for protection or nurturing, just as a child would, while at the same time offering a harmonious, conflict-free relationship, like a deep friendship.
But unlike human relationships, those with dogs are based on a clear asymmetry of power. The owner decides everything and controls the animal's environment, creating a particular dynamic that is both stable and rewarding for the human. 'The power asymmetry, having control over a living being, is a fundamental aspect of dog ownership for many,' explains senior author Enikő Kubinyi, head of the Department of Ethology at the ELTE, quoted in a news release.
Another striking fact is that participants consider their relationship with their dog to be the most precious, far above all others. For them, their four-legged friend is both their most loyal companion and the one who shows them the most affection. The researchers also observed that the more a person has strong human relationships, the more they develop a deep and harmonious bond with their dog.
Long confined to practical roles, dogs are now central to the lives of many families. This is reflected in the emergence of the terms 'dog moms' and 'dog dads' to designate people who no longer see themselves as dog owners, but as pet parents, caring for their dog's well-being and showing their pet affection, as they would with a child. This reveals a profound change in the status of dogs in today's society.
This study highlights the unique role that domestic dogs play: that of an ideal blend of unconditional affection, relationship stability and absence of conflict. This mix may well explain why these animals occupy such a special place in the hearts of so many humans. — ETX Studio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
08-07-2025
- Malaysian Reserve
Caris Life Sciences Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure® Blood-Based Assay for Multi-Cancer Early Detection, Minimal Residual Disease and Therapy Selec
Scientific Reports study validates the first multifunctional, AI-enabled blood-based assay to offer diagnostic, prognostic and predictive utility in a single assay. IRVING, Texas, July 8, 2025 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, announced a landmark study published in Scientific Reports, a Nature journal, demonstrating the accuracy and clinical utility of the Caris Assure® blood-based biopsy assay across the cancer continuum. The Caris Assure® platform is a breakthrough single assay that combines comprehensive, highly sophisticated molecular profiling of all 23,000+ genes across DNA and RNA in plasma, setting a new blood-based testing standard and revolutionizing management of the cancer care journey. Additionally, Caris sequences DNA in the 'buffy coat,' the layer of centrifuged blood between the red blood cells and plasma, which contains white blood cells and platelets. Caris Assure combines Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) with advanced machine learning on a single platform. Caris Assure® is currently used for therapy selection and is capable of enabling accurate early detection and highly sensitive disease monitoring. 'We designed Caris Assure® to be more than a liquid biopsy test. This assay takes advantage of advanced sequencing and computing technology to capture genetic information available from the whole exome and whole transcriptome from the tumor material circulating in the blood and DNA from the patient's white blood cells,' said David Spetzler, MS, PhD, MBA, President of Caris. 'This enables us to provide a very comprehensive individualized picture of a patient's specific disease state. This is the first time so much molecular information has been available from a single blood test, allowing for increased accuracy and additional insights to inform physicians in helping to make cancer care decisions.' The Caris Assure® liquid biopsy platform, powered by the Assure Blood-based Cancer Detection AI (ABCDai), was trained on over 376,000 whole exome and whole transcriptome tissue profiles and over 7,000 matched blood and tissue samples. In addition to therapy selection, the study validates the performance of Caris Assure® in: Multi-Cancer Early Detection (MCED): Achieved sensitivities of 83.1% to 95.7% across cancer stages I–IV at 99.6% specificity. Diagnostic Pathway Predictor: Accurately identified the diagnostic pathway for MCED-positive cancers using the ABCDai-GPS model. MRD and Recurrence Monitoring: Demonstrated significant predictive power for recurrence, with hazard ratios of 33.4 (p < 0.005) for MRD and 4.39 (p = 0.008) for therapeutic monitoring. Caris Assure® does not require a prior tissue biopsy. Instead, its AI model identifies tumor-derived signals based on patterns learned from hundreds of thousands of tumors. This enables a tissue-agnostic, highly sensitive approach to cancer detection and monitoring. While Caris Assure® is currently commercially available for therapy selection in advanced cancers, this study lays the groundwork for expanding into early detection, MRD and therapeutic monitoring. Caris is actively pursuing reimbursement and regulatory pathways to bring these applications to market. 'This is more than a validation study; it is a blueprint for the future of cancer diagnostics,' added Spetzler. 'Our goal is to create a seamless ecosystem where patients and clinicians can rely on one platform throughout the entire cancer journey.' About Caris Life Sciences Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms at scale, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies, and high-performance computing provides a differentiated platform to develop the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development. Caris was founded with the belief and vision that combining a vast set of consistently generated molecular information with robust data-driven insights could realize the potential of precision medicine for patients. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S. and other international markets. The Scientific Report study is available on Forward Looking Statements:This press release contains forward-looking statements, within the meaning of the federal securities laws, about Caris Life Sciences and its business. Statements about the performance and accuracy of Caris Assure discussed in this press release are based on testing and analysis to date, as reflected in the publication discussed, and future results and performance may differ materially from these findings. All statements other than statements of historical facts contained in this press release are forward-looking statements. In some cases forward-looking statements can be identified by words such as 'may,' 'will,' 'should,' 'would,' 'expect,' 'plan,' 'anticipate,' 'could,' 'intend,' 'target,' 'project,' 'potential,' 'contemplate,' 'believe,' 'estimate,' 'predict,' 'potential' or 'continue' or similar expressions. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in these forward-looking statements are reasonable based on information currently available to us, we cannot guarantee that the future results, discoveries, levels of activity, performance or events and circumstances reflected in forward-looking statements will be achieved or occur. Forward-looking statements involve known and unknown risks and uncertainties, some of which are beyond our control. Risks and uncertainties that could cause our actual results to differ materially from those indicated or implied by the forward-looking statements in this press release include, among other things: developments in the precision oncology industry; future financial performance, results of operations or other operational results or metrics; development, validation and timing of future solutions; the rapidly evolving competitive environment in which we operate; third-party payer reimbursement and coverage decisions; our ability to protect and enhance our intellectual property; regulatory requirements, decisions or approvals (including the timing and conditions thereof) related to our solutions; our compliance with laws and regulations; and our ability to hire and retain key personnel as well as risks, uncertainties, and other factors described in the section titled 'Risk Factors' and elsewhere in the prospectus for our initial public offering filed with the Securities and Exchange Commission on June 20, 2025, and in our other filings we make with the SEC from time to time. We undertake no obligation to update any forward-looking statements to reflect changes in events, circumstances or our beliefs after the date of this press release, except as required by law. Caris Life Sciences Media: Corporate CommunicationsCorpComm@ Investor Relations:Narendra ChokshiSenior Vice President, Corporate Developmentnchokshi@
The Star
07-07-2025
- The Star
QuickCheck: Was the first known aeroplane hijacking carried out by the 'Father of Paleobiology'?
THE history of aviation is filled with groundbreaking moments, but one early event stands out for its sheer audacity. In the chaotic aftermath of a world war, a desperate individual took extreme measures to escape a volatile political situation. Was the very first known aeroplane hijacking committed by the 'Father of Paleobiology'? Verdict: TRUE On a clear November day in 1919, an extraordinary event took place that would later be recognised as the world's first known aeroplane hijacking. Baron Franz Nopcsa von Felső-Szilvás, a Hungarian aristocrat, found himself facing the turbulent political climate of the nascent (but short-lived) Hungarian Soviet Republic in Hungary. Being a nobleman, he was desperate to escape as the murders of Tsar Nicholas II of Russia and the rest of the Russian royal family by the Communists were still fresh in everyone's minds. However, as he had served as a spy for the Austro-Hungarian Empire during World War I, he had a particular set of skills which proved very useful to him in his time of need. Nopsca forged a set of documents from the Hungarian War Ministry that "authorised" him to requisition a small aircraft and a pilot, ostensibly for a flight from Budapest to Sopron. After boarding the plane with his Albanian secretary, Bajazid Doda, Nopcsa produced a pistol and demanded that their course be immediately changed to Vienna. The pilot, under duress, complied with Nopcsa's demands, successfully diverting the aircraft and landing them safely in Vienna. As mentioned earlier, Nopcsa is often hailed as the 'Father of Paleobiology', as he was among the first to propose that dinosaurs were warm-blooded and exhibited social behaviours. At a time when palaeontologists were mainly interested in assembling bones, he tried to deduce the physiology and living behaviour of the dinosaurs he was studying. Another of his theories, which was ahead of its time, was that birds evolved from dinosaurs. Baron Franz Nopcsa von Felso-Szilvas in Shqiptar warrior costume, cca 1913 He also discovered and named several dinosaur species, including Magyarosaurus. Aside from dinosaurs, Nopsca was also very passionate about Albania. Beyond his scientific pursuits, Nopcsa harboured a deep fascination with Albania. He became a fervent advocate for Albanian independence and culture, learning the language and travelling extensively through the region. His comprehensive work, "Albania: A Study of Its Past, Present, and Future," published in 1925, remains a significant ethnographic and geological account of the country. His ambition extended to politics, as he famously attempted to become the King of Albania in 1913, following the country's declaration of independence from the Ottoman Empire, but he was ultimately unsuccessful. His life was a complex tapestry of scientific breakthroughs, political machinations, intrigue and personal struggles. The aeroplane hijacking was a desperate measure taken amidst the collapse of the Austro-Hungarian Empire and the rise of the Hungarian Soviet Republic, a final, dramatic attempt to escape his circumstances. This audacious act allowed him to flee his troubles, marking a bizarre footnote in the history of aviation. Sources: 1. com/history/history-forgot- rogue-aristocrat-discovered- dinosaurs-died-penniless- 180959504/ 2. history-of-geology/baron- nopcsa-more-than-just- transylvanian-dinosaurs/ 3. 02387/00039/pdf/EPA02387_osi_ gyoker_2017_1-2_018
The Star
03-07-2025
- The Star
Dogs are being seen as children as pet ownership increases
Affection, vulnerable and totally dependent on their humans, dogs share many characteristics with children. These similarities may explain why some people refer to their pets as their 'babies', suggests a Hungarian study. This increasingly common anthropomorphic trend nevertheless raises ethical questions. In developed countries, the domesticated dog has become much more than a simple pet – it's often considered a family member in its own right. This is a relatively recent phenomenon, and one that has given rise to a forthright anthropomorphisation of our pets. In fact, it's no longer unusual for dogs adopted by Millennials or Gen Zs to have their own Instagram or TikTok accounts. The phenomenon is so widespread, particularly in Europe, East Asia and North America, that dogs are frequently referred to as 'fur babies'. Nothing is too good when it comes to offering these pooches the very best, as can be seen with the proliferation of dog-related products and services over the last few decades, including luxury grooming salons, strollers, dog parks and doggie daycare. There are even restaurants for dogs! Evident analogy The analogy with a young child is sometimes evident, and owners don't shy away from it: some even refer to their dog as their 'child' or 'baby'. Whether it's a way to ease loneliness, the satisfaction of having a dependent being to protect and train, or the feeling of being useful or needed, there are many reasons why these canines are perceived as child substitutes. A team of Hungarian researchers from the Department of Ethology at ELTE Eotvos Lorand University (Budapest) has studied this phenomenon in Western societies. Published in the journal European Psychologist, their study highlights several factors that may explain the phenomenon of likening dogs to children. One is that dogs' cognitive abilities and adaptability to human communication enable them to adopt a wide range of social behaviours, often comparable to those of pre-verbal children. But their morphology could also play a role in this association. In particular, the researchers link the appeal of small dogs – especially brachycephalic breeds like French bulldogs and pugs – to infantile traits that can make them appear 'as helpless, harmless and innocent as small children.' Seen as children... but not quite as humans In the light of these arguments, it's easy to understand why some people call themselves 'dog parents' rather than 'masters' or 'owners' of their pets. But there are nevertheless some key differences. 'Despite the high dependency and attachment of dogs to their caregivers, in the eyes of many, commitments coming with dog ownership remain less burdensome than child parenting,' explains Laura Gillet, a PhD student at the Department of Ethology and coauthor of the study, quoted in a news release. Another difference is that, since dogs don't live as long as humans, their owners generally assume that they will outlive them – which is obviously not the case with a child. 'While some owners might see their dog as a child surrogate to spoil, others actively choose to have dogs and not children, bearing in mind that they have species-specific characteristics and needs,' the study authors write. They point out that, contrary to popular belief, only a small minority of dog owners actually treat their pets like human children. 'In most cases, dog parents choose dogs precisely because they are not like children, and they acknowledge their species- specific needs,' explains study coauthor, Eniko Kubinyi. These researchers are not new to the subject. They have also carried out another study published in the journal Scientific Reports. Involving over 700 dog owners, the research compared the relationships we have with our dogs to those we have with our loved ones. The results reveal that, in the eyes of their owners, dogs are more than just loyal companions: they combine the qualities of a child with those of a best friend. They inspire a sense of security and the need for protection, just as a child would, while at the same time offering a harmonious, conflict-free relationship, similar to a deep friendship. – AFP Relaxnews
